← SynDRA
PALOSURAN
SynDRA canonical compound SYN0020310 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | UTS2R |
| Mechanism of action | urotensin receptor antagonist |
All known targets
Mechanisms of action (all sources)
- UTS2R ANTAGONIST
- Urotensin II receptor antagonist
- urotensin receptor antagonist
- UTS2R INHIBITOR
Cross-references
Synonyms
- Act-058362
- ACT 058362
- UNII-ULD9ZKE457
- 1-(2-(4-Benzyl-4-hydroxypiperidin-1-yl)ethyl)-3-(2-methylquinolin-4-yl)urea
- ULD9ZKE457
- CHEMBL567303
- Palosuran [INN]
- 1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)ethyl]-3-(2-methylquinolin-4-yl)urea
- ACT058362 (Palosuran)
- GTPL3516
- SCHEMBL1363480
- DTXSID00202406
- WYJCYXOCHXWTHG-UHFFFAOYSA-N
- BCP15786
- BDBM50302272
- ZINC34375693
- AKOS026750332
- 1-(2-(4-Benzyl-4-hydroxypiperidin-1-yl)ethyl-3-(2-methylquinolin-4-yl)urea
- CS-1722
- NCGC00408890-01
- ACT-058362
- palosuranum
- RefChem:169773
- DTXCID60124897
- ACT058362
- MFCD07772352
- ACT 058362; Palosuran
- orb1705555
- SCHEMBL29441424
- AC-35242
- DA-76574
- HY-10655
- MS-27325
- BRD-K07682953-001-01-8
- GLXC-90149
- ACT-058362 sulfate
- SCHEMBL5265025
Look up PALOSURAN in the interactive SynDRA portal →